Completed NA INTERVENTIONAL 1-arm NCT02351999

Clinical Study of the TSP Crosser System for Transseptal Access and Left Atrial Catheter Navigation

Clinical Study of the TSP Crosser System For Transseptal Access and Left Atrial Catheter Navigation in Patients Undergoing Atrial Fibrillation Ablation

Sponsor: Meditrial Europe Ltd.

Conditions Atrial Fibrillation

Interventions TSP Crosser Transseptal Access System

Updated 7 times since 2017 Last updated: Nov 13, 2019 Started: Jun 15, 2015 Primary completion: Sep 30, 2018 Completion: Apr 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02351999, this NA trial focuses on Atrial Fibrillation and remains completed. Sponsored by Meditrial Europe Ltd., it has been updated 7 times since 2015, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Jun 2018 — Dec 2019 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

May 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — May 2018 [monthly]

Recruiting NA

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Meditrial Europe Ltd.
Transseptal Solutions Ltd.

Data source: Transseptal Solutions Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany
• Paris, France